Ethambutol
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| |
| Ethambutol
| |
| Systematic (IUPAC) name | |
| 2-[2-(1-hydroxybutan-2-ylamino)ethylamino]butan-1-ol | |
| Identifiers | |
| CAS number | |
| ATC code | J04 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C10H24N2O2 |
| Mol. mass | 204.31 g/mol |
| Pharmacokinetic data | |
| Bioavailability | Well-absorbed from GI tract |
| Protein binding | 20 to 30% |
| Metabolism | Liver |
| Half life | 3-4 hr (increased in impaired renal function) |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
B |
| Legal status | |
| Routes | oral |
|
WikiDoc Resources for Ethambutol | |
|
Articles | |
|---|---|
|
Most recent articles on Ethambutol | |
|
Media | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Ethambutol at Clinical Trials.gov Clinical Trials on Ethambutol at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Ethambutol
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Ethambutol Discussion groups on Ethambutol Patient Handouts on Ethambutol Directions to Hospitals Treating Ethambutol Risk calculators and risk factors for Ethambutol
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Ethambutol | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Ethambutol is a bacteriostatic antimycobacterial drug prescribed to treat tuberculosis (Mycobacterium tuberculosis). It is usually given in combination with other tuberculosis drugs, such as isoniazid, pyrazinamide and rifampicin.
It is sold under the name "Myambutol".
Bacteriostatic against actively growing TB bacilli, it works by obstructing the formation of cell wall. Mycolic acids attach to the 5'-hydroxyl groups of D-arabinose residues of arabinogalactan and form mycolyl-arabinogalactan-peptidoglycan complex in the cell wall. Disruption of the arabinogalactan synthesis inhibits the formation of this complex and leads to increased permeability of the cell wall.
Pharmacokinetics
It is well absorbed from the gastrointestinal tract and well distributed in body tissues and fluids, 50% is execreted unchanged in urine.
Side Effects
External link
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
